Ultragenyx Pharmaceutical(CH:UP0)
CHF 13.45-0.32 (-2.34%)
CH:UP0
Ultragenyx Pharmaceutical earnings date
CHF 13.45
At close:-0.32 (-2.34%)
Ultragenyx Pharmaceutical (UP0) Q4 2023 Earnings Report
0 Followers
CH:UP0 Q4 2023 EPS Results
- Actual EPS
- -CHF 1.27
- Consensus EPS
- -CHF 1.43
- Beat/Miss
- Beat by +CHF 0.16
- One Year Ago EPS
- -CHF 1.80
CH:UP0 Q4 2023 Revenue Results
- Actual Revenue
- CHF 106.41M
- Expected Revenue
- CHF 99.72M
- Beat/Miss
- Beat by +CHF 6.69M
- YoY Revenue Growth
- +23.27%
Earnings Announcement Details
- Quarter
- Q4 2023
- Date
- 02/15/2024
- Time
- After Close
- Conference Call
- Thursday, February 15, 2024
CH:UP0 Upcoming Earnings
Ultragenyx Pharmaceutical's next earnings date is estimated for February 18, 2027, based on past reporting schedules.
Q4 2023 Earnings Call Audio
CH:UP0 Q4 2023 Earnings Call
0:00 / 0:00
Q4 2023 Earnings Slide Deck
Q4 2023 Earnings Call Summary
No earnings call summary is available for this earnings event.
CH:UP0 Earnings History
| Report Date | Fiscal Quarter | Forecast / EPS | Last Year's EPS | EPS YoY Change | Press Release |
|---|---|---|---|---|---|
| Feb 18, 2027 | 2026 (Q4) | 2.00- | -1.08 | ― | ― |
| Nov 03, 2026 | 2026 (Q3) | -0.92-0.97 | -1.51 | 35.91% (+0.54) | |
| Aug 04, 2026 | 2026 (Q2) | -1.04-0.75 | -0.98 | 23.08% (+0.23) | |
| May 05, 2026 | 2026 (Q1) | -1.24-1.54 | -1.31 | -17.20% (-0.23) | |
| Feb 12, 2026 | 2025 (Q4) | -0.91-1.08 | -1.16 | 7.19% (+0.08) | |
| Nov 04, 2025 | 2025 (Q3) | -1.03-1.51 | -1.17 | -29.29% (-0.34) | |
| Aug 05, 2025 | 2025 (Q2) | -1.08-0.98 | -1.27 | 23.03% (+0.29) | |
| May 06, 2025 | 2025 (Q1) | -1.33-1.31 | -1.7 | 22.66% (+0.38) | |
| Feb 13, 2025 | 2024 (Q4) | -1.09-1.16 | -1.27 | 8.55% (+0.11) | |
| Nov 05, 2024 | 2024 (Q3) | -1.24-1.17 | -1.86 | 37.22% (+0.69) |
The table shows recent earnings report dates and whether the forecast was beat or missed. See the change in forecast and EPS from the previous year.
Beat Missed


